NervGen Pharma Corp. (NGEN)
1.43
+0.01
(+0.70%)
USD |
NASDAQ |
Oct 23, 16:00
1.42
-0.01
(-0.70%)
After-Hours: 20:00
NervGen Pharma Price : 1.43 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.41 | 1.442 | 1.38 | 1.43 | 944031.0 |
| Oct 22, 2026 | 1.50 | 1.51 | 1.415 | 1.42 | 628502.0 |
| Oct 21, 2026 | 1.54 | 1.55 | 1.50 | 1.50 | 297514.0 |
| Oct 20, 2026 | 1.53 | 1.589 | 1.52 | 1.54 | 228374.0 |
| Oct 19, 2026 | 1.59 | 1.61 | 1.53 | 1.54 | 423077.0 |
| Oct 16, 2026 | 1.63 | 1.66 | 1.58 | 1.59 | 388391.0 |
| Oct 15, 2026 | 1.59 | 1.66 | 1.55 | 1.62 | 475280.0 |
| Oct 14, 2026 | 1.65 | 1.65 | 1.55 | 1.565 | 1.299M |
| Oct 13, 2026 | 1.74 | 1.792 | 1.615 | 1.63 | 506482.0 |
| Oct 12, 2026 | 1.75 | 1.79 | 1.71 | 1.73 | 220505.0 |
| Oct 09, 2026 | 1.75 | 1.80 | 1.705 | 1.73 | 293220.0 |
| Oct 08, 2026 | 1.74 | 1.810 | 1.72 | 1.75 | 288976.0 |
| Oct 07, 2026 | 1.78 | 1.785 | 1.73 | 1.74 | 231505.0 |
| Oct 06, 2026 | 1.81 | 1.82 | 1.73 | 1.75 | 297809.0 |
| Oct 05, 2026 | 1.78 | 1.88 | 1.78 | 1.81 | 441039.0 |
| Oct 02, 2026 | 1.78 | 1.90 | 1.74 | 1.78 | 409597.0 |
| Oct 01, 2026 | 1.92 | 1.92 | 1.730 | 1.76 | 1.051M |
| Sep 30, 2026 | 1.91 | 1.98 | 1.90 | 1.91 | 548694.0 |
| Sep 29, 2026 | 1.86 | 1.96 | 1.84 | 1.92 | 560132.0 |
| Sep 28, 2026 | 1.89 | 1.99 | 1.88 | 1.88 | 525401.0 |
| Sep 25, 2026 | 2.00 | 2.01 | 1.915 | 1.94 | 343204.0 |
| Sep 24, 2026 | 1.98 | 2.02 | 1.91 | 2.02 | 317136.0 |
| Sep 23, 2026 | 2.05 | 2.093 | 1.955 | 1.96 | 536653.0 |
| Sep 22, 2026 | 2.00 | 2.10 | 1.99 | 2.065 | 223722.0 |
| Sep 21, 2026 | 2.06 | 2.06 | 1.96 | 1.99 | 473668.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InMed Pharmaceuticals, Inc. | 1.44 |
| Milestone Pharmaceuticals, Inc. | 0.6482 |
| Appili Therapeutics, Inc. | 0.0068 |
| Clearmind Medicine, Inc. | 5.87 |
| Lexaria Bioscience Corp. | 3.08 |
Price Related Metrics
| PEG Ratio | -0.076 |
| Price to Book Value | 4.609 |
| Earnings Yield | -27.98% |
| Market Cap | 152.17M |
| PEGY Ratio | -0.076 |